AAAAAA

   
Results: 1-7 |
Results: 7

Authors: CLARKE R BREEZE E SHERLIKER P SHIPLEY M YOUNGMAN L FLETCHER A FUHRER R LEON D PARISH S COLLINS R MARMOT M
Citation: R. Clarke et al., DESIGN, OBJECTIVES, AND LESSONS FROM A PILOT 25-YEAR FOLLOW-UP RE-SURVEY OF SURVIVORS IN THE WHITEHALL STUDY OF LONDON CIVIL-SERVANTS, Journal of epidemiology and community health, 52(6), 1998, pp. 364-369

Authors: DILLNER J LEHTINEN M BJORGE T LUOSTARINEN T YOUNGMAN L JELLUM E KOSKELA P GISLEFOSS RE HALLMANS G PAAVONEN J SAPP M SCHILLER JT HAKULINEN T THORESEN S HAKAMA M
Citation: J. Dillner et al., PROSPECTIVE SEROEPIDEMIOLOGIC STUDY OF HUMAN-PAPILLOMAVIRUS INFECTIONAS A RISK FACTOR FOR INVASIVE CERVICAL-CANCER, Journal of the National Cancer Institute, 89(17), 1997, pp. 1293-1299

Authors: BJORGE T DILLNER J ANTTILA T ENGELAND A HAKULINEN T JELLUM E LEHTINEN M LUOSTARINEN T PAAVONEN J PUKKALA E SAPP M SCHILLER J YOUNGMAN L THORESEN S
Citation: T. Bjorge et al., PROSPECTIVE SEROEPIDEMIOLOGICAL STUDY OF ROLE OF HUMAN-PAPILLOMAVIRUSIN NON-CERVICAL ANOGENITAL CANCERS, BMJ. British medical journal, 315(7109), 1997, pp. 646-649

Authors: BJORGE T HAKULINEN T ENGELAND A JELLUM E KOSKELA P LEHTINEN M LUOSTARINEN T PAAVONEN J SAPP M SCHILLER J THORESEN S WANG ZH YOUNGMAN L DILLNER J
Citation: T. Bjorge et al., A PROSPECTIVE, SEROEPIDEMIOLOGICAL STUDY OF THE ROLE OF HUMAN-PAPILLOMAVIRUS IN ESOPHAGEAL CANCER IN NORWAY, Cancer research, 57(18), 1997, pp. 3989-3992

Authors: PARISH S COLLINS R PETO R YOUNGMAN L BARTON J JAYNE K CLARKE R APPLEBY P LYON V CEDERHOLMWILLIAMS S MARSHALL J SLEIGHT P
Citation: S. Parish et al., CIGARETTE-SMOKING, TAR YIELDS, AND NONFATAL MYOCARDIAL-INFARCTION - 14000 CASES AND 32000 CONTROLS IN THE UNITED-KINGDOM, BMJ. British medical journal, 311(7003), 1995, pp. 471-477

Authors: KEECH A COLLINS R MACMAHON S ARMITAGE J LAWSON A WALLENDSZUS K FATEMIAN M KEARNEY E LYON V MINDELL J MOUNT J PAINTER R PARISH S SLAVIN B SLEIGHT P YOUNGMAN L PETO R
Citation: A. Keech et al., 3-YEAR FOLLOW-UP OF THE OXFORD-CHOLESTEROL-STUDY - ASSESSMENT OF THE EFFICACY AND SAFETY OF SIMVASTATIN IN PREPARATION FOR A LARGE MORTALITY STUDY, European heart journal, 15(2), 1994, pp. 255-269

Authors: HUNT D VARIGOS J DIENSTL F LECHLEITNER P DEBACKER G KORNITZER M CAIRNS J TURPIE A FRITZHANSEN P SKAGEN K KALA R HEIKKILA J BOISSEL JP LEIZOROVICZ A SCHRODER R KOTHE K KARATZAS N HORGAN J OCALLAGHAN D TOGNONI G FRANZOSI MG MAGGIONI A COHEN A KOSTER R WHITE H MACMAHON S KJEKSHUS J REIKVAM A CEREMUZYNSKI L PAOLASSO E DIAZ R VALENTIN V WILHELMSEN L LUNDKVIST L MOCCETTI T MALACRIDA R GENONI M COLLINS R SLEIGHT P PETO R PARISH S DOLL R ARMITAGE P CEDERHOLMWILLIAMS S CONWAY M DOVE P FLATHER M MARSHALL J YOUNGMAN L JULIAN D CHAMBERLAIN D WARLOW C SANDERCOCK P FOX K HENNEKENS C GOLDHABER S TIMMIS G YUSUF S MEIER P
Citation: D. Hunt et al., ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION, Lancet, 339(8796), 1992, pp. 753-770
Risultati: 1-7 |